Drug Profile
Pandemic influenza virus vaccine - AlphaVax
Alternative Names: H1N1 influenza vaccine - AlphaVax; H5N1 influenza vaccine - AlphaVax; Pandemic influenza vaccine (H1B and H5) - AlphaVaxLatest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator AlphaVax
- Class Influenza A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for phase-I development in Influenza-A-virus-H1N1-subtype in USA (Parenteral)
- 28 Jun 2021 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype in USA (Parenteral)
- 07 May 2018 Phase-I clinical trials in Influenza-A virus H1N1 subtype in USA (Parenteral) (AlphaVax pipeline, May 2018)